Sylvie Rottey

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

Udai Banerji, Carla M.L. van Herpen, Cristina Saura et al. · The Lancet Oncology · 2019 · 565 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

Axel Bex, Peter F.A. Mulders, Michael A.S. Jewett et al. · JAMA Oncology · 2018 · 490 citations · Full text

Medicine, Oncology, Surgery +17

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Jan B. Vermorken, Jan Stöhlmacher-Williams, Lisa Licitra et al. · The Lancet Oncology · 2013 · 433 citations · Full text

Medicine, Oncology, Chemotherapy +10

Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma

Thomas E. Hutson, Ian D. Davis, Jean‐Pascal Machiels et al. · Journal of Clinical Oncology · 2009 · 293 citations

Medicine, Pharmacology, Pharmacotherapy +14